16.58
price up icon0.06%   0.010
after-market Dopo l'orario di chiusura: 16.59 0.01 +0.06%
loading

Takeda Pharmaceutical Co Adr Borsa (TAK) Ultime notizie

pulisher
01:48 AM

Jury Hits Takeda With $885 Million Antitrust Verdict - Benzinga

01:48 AM
pulisher
May 18, 2026

Takeda Pharmaceutical stock (JP3730800003): earnings in focus as investors weigh legal risks - AD HOC NEWS

May 18, 2026
pulisher
May 16, 2026

Takeda Pharmaceutical stock (JP3730800003): recent earnings and Rybelsus biosimilar plans in focus - AD HOC NEWS

May 16, 2026
pulisher
May 15, 2026

Takeda Pharmaceutical Co Ltd stock (JP3730800003): earnings beat but softer EPS outlook - AD HOC NEWS

May 15, 2026
pulisher
May 15, 2026

TAK Stock Price, Quote & Chart | TAKEDA PHARMACEUTIC-SP ADR (NYSE:TAK) - ChartMill

May 15, 2026
pulisher
May 14, 2026

Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline - Morningstar

May 14, 2026
pulisher
May 14, 2026

Earnings call transcript: Takeda beats EPS expectations in Q4 2025 By Investing.com - Investing.com Australia

May 14, 2026
pulisher
May 14, 2026

Earnings call transcript: Takeda beats EPS expectations in Q4 2025 - Investing.com

May 14, 2026
pulisher
May 14, 2026

Takeda Pharmaceutical stock (JP3730800003): FY2026 profit surges 77.7%, but FY2027 guidance signals - AD HOC NEWS

May 14, 2026
pulisher
May 14, 2026

Takeda Pharma ADR earnings beat by $0.03, revenue fell short of estimates - Investing.com Canada

May 14, 2026
pulisher
May 13, 2026

Takeda Surpasses Earnings Estimates Despite Revenue Miss - HarianBasis.co

May 13, 2026
pulisher
May 13, 2026

What's Going On With Takeda Stock Wednesday?Takeda Pharmaceutical Co (NYSE:TAK) - Benzinga

May 13, 2026
pulisher
May 13, 2026

Earnings call transcript: Takeda’s Q4 2025 performance highlights resilience - Investing.com

May 13, 2026
pulisher
May 12, 2026

Takeda Pharmaceutical stock (JP3730800003): Q4 2026 earnings report released - AD HOC NEWS

May 12, 2026
pulisher
May 01, 2026

Takeda Pharmaceutical Co Ltd (FRA:TKDA) Bonds - GuruFocus

May 01, 2026
pulisher
Apr 29, 2026

Takeda Pharmaceutical Co Ltd stock (JP3730800003): Is its rare disease focus strong enough to unlock - AD HOC NEWS

Apr 29, 2026
pulisher
Apr 26, 2026

Takeda Pharmaceutical Co Ltd (HAM:TKDA) Stock News, Headlines & Updates - GuruFocus

Apr 26, 2026
pulisher
Apr 26, 2026

Takeda Pharmaceutical Co Ltd Stock Baskets - GuruFocus

Apr 26, 2026
pulisher
Apr 19, 2026

Takeda Pharmaceutical (ADR) stock (US8740602052): Why Google Discover changes matter more now - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 11, 2026

Takeda Pharmaceutical Co Ltd (HAM:TKDA) Competitors 2026 - GuruFocus

Apr 11, 2026
pulisher
Apr 10, 2026

Takeda Pharmaceutical Co Ltd Stock Operating Data - GuruFocus

Apr 10, 2026
pulisher
Apr 08, 2026

Takeda Pharmaceutical Co Ltd stock: What you should know now for smart investing - AD HOC NEWS

Apr 08, 2026
pulisher
Apr 06, 2026

Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Benzinga

Apr 06, 2026
pulisher
Apr 05, 2026

Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history - Yahoo Finance Singapore

Apr 05, 2026
pulisher
Apr 05, 2026

Takeda Pharmaceutical Company Limited (TAK) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 05, 2026
pulisher
Apr 03, 2026

Takeda Pharmaceutical Co Ltd (HAM:TKDA) Stock HoldersInstitutional & Insider Ownership - GuruFocus

Apr 03, 2026
pulisher
Mar 30, 2026

Takeda Pharmaceutical (ADR) Stock: A Stable Global Pharma Play with Focus on Oncology and Rare Disea - AD HOC NEWS

Mar 30, 2026
pulisher
Mar 29, 2026

Who's Buying or Selling Takeda Pharmaceutical Co Ltd (HAM:TKDA) Stock Today? - gurufocus.com

Mar 29, 2026
pulisher
Mar 29, 2026

Takeda Pharmaceutical Co Ltd Stock Intrinsic Values | HAM:TKDA - GuruFocus

Mar 29, 2026
pulisher
Mar 29, 2026

Takeda Pharmaceutical Co Ltd Stock Historical Valuations | HAM:TKDA - GuruFocus

Mar 29, 2026
pulisher
Mar 27, 2026

Takeda Pharmaceutical Co Ltd (LTS:0A87) Bonds - GuruFocus

Mar 27, 2026
pulisher
Mar 26, 2026

Takeda Pharmaceutical stock faces pressure from geopolitical risks amid pipeline advances - AD HOC NEWS

Mar 26, 2026
pulisher
Mar 25, 2026

Takeda Pharmaceutical (ADR) stock faces pressure amid pipeline setbacks and competitive oncology cha - AD HOC NEWS

Mar 25, 2026
pulisher
Mar 25, 2026

Takeda: 'Hold' Despite Performance In 2025-2026 (NYSE:TAK) - Seeking Alpha

Mar 25, 2026
pulisher
Mar 14, 2026

Takeda Pharmaceutical (ADR) Stock Steady Amid Pharma Sector Volatility as Investors Eye Pipeline Pro - AD HOC NEWS

Mar 14, 2026
pulisher
Mar 13, 2026

Takeda Pharmaceutical Co Ltd (HAM:TKDA)Valuation Measures & Financial Statistics - GuruFocus

Mar 13, 2026
pulisher
Mar 08, 2026

FDA Grants Priority Review for Takeda (TAK) and Protagonist's Rusfertide in PV Treatment - Finviz

Mar 08, 2026
pulisher
Feb 27, 2026

DNLI Q4 Loss Narrower Than Expected, Hunter Syndrome Drug in Focus - Finviz

Feb 27, 2026
pulisher
Feb 22, 2026

Takeda Stock: Quiet Japan Pharma With a Big U.S. Pipeline Bet - AD HOC NEWS

Feb 22, 2026
pulisher
Feb 21, 2026

Takeda Stock: Quiet Pharma Giant That US Investors Keep Missing - AD HOC NEWS

Feb 21, 2026
HLN HLN
$9.20
price up icon 0.33%
$34.07
price up icon 0.12%
ZTS ZTS
$78.92
price up icon 1.54%
$566.80
price down icon 0.03%
$16.17
price down icon 2.00%
Capitalizzazione:     |  Volume (24 ore):